In TNBC, the TGF-β-induced EMT pathway significantly contributes to chemoresistance, as the transition to a mesenchymal state [86] is associated with potentially reduced drug sensitivity and enhanced survival of cancer cells. This evidence concerns the gene TGFB1 and cancer.